Skip to main content
Login
Contact
Subscribe
Search form
Search
The Borger News-Herald
Home
Forms
News
Sports
Obituaries
Classifieds
Place an Ad
Classified Display Ads
Service Directory
Photos
Videos
Games
Entertainment
Calendar
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Global Blood Ther
(NQ:
GBT
)
39.97
USD
-0.80 (-1.96%)
Official Closing Price
Updated: 5:57 PM EDT, Apr 12, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All news about Global Blood Ther
< Previous
1
2
3
4
5
6
7
8
9
...
27
28
Next >
Global Blood Therapeutics' Sickle Cell Med Results In Rapid, Durable Improvements In Hemoglobin Levels Throughout 72 Weeks Of Treatment
April 08, 2021
Global Blood Therapeutics Inc(NASDAQ:GBT) has announced The Lancet Haematology haspublished the complete analysis ...
Tags
sickle cell
Market News
Benzinga
From
Benzinga
Complete 72-Week Results from Phase 3 HOPE Study of Oxbryta® (voxelotor) Tablets Published in The Lancet Haematology Show Significantly Improved Hemoglobin, Hemolysis and Overall Health Status in Sick
April 08, 2021
From
GlobeNewswire News Releases
GBT Announces New Employment Inducement Grants
April 05, 2021
From
GlobeNewswire News Releases
Analysts Anticipate 10% Upside For ESGV
March 26, 2021
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Tags
ETFs
From
ETF Channel
GBT Appoints Alexis A. Thompson, M.D., M.P.H., to Board of Directors
March 18, 2021
From
GlobeNewswire News Releases
GBT In-Licenses Two Sickle Cell Disease Programs From Sanofi
March 16, 2021
Global Blood Therapeutics Inc(NASDAQ:GBT) hasexclusively in-licensed worldwide rightsto two early-stage research ...
Tags
Health Care
SNY
Contracts
From
Benzinga
GBT Expands Sickle Cell Disease Pipeline with Exclusive In-license of Two Novel Small Molecule Programs from Sanofi S.A.
March 16, 2021
From
GlobeNewswire News Releases
GBT Announces New Employment Inducement Grants
March 08, 2021
From
GlobeNewswire News Releases
GBT Opens 2021 ACCEL Grant Program, Providing up to $500,000 in Support to the Sickle Cell Disease Community
March 02, 2021
Grant proposals from community-based organizations and institutions accepted through April 23, 2021
From
GlobeNewswire News Releases
GBT Announces Participation at the H.C. Wainwright Global Life Sciences Conference
March 02, 2021
From
GlobeNewswire News Releases
The Daily Biotech Pulse: Merck Goes Shopping, Decision Day For Sarepta, Pfizer, Moderna Unveil Vaccine Strategies For Coronavirus Variants
February 25, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...
Tags
SLDB
NTUS
EDIT
From
Benzinga
Global Blood Therapeutics (GBT) Q4 2020 Earnings Call Transcript
February 25, 2021
GBT earnings call for the period ending December 31, 2020.
Tags
GBT
Market News
From
Motley Fool
Recap: Global Blood Therapeutics Q4 Earnings
February 24, 2021
Shares of Global Blood Therapeutics (NASDAQ:GBT) decreased in after-market trading after the company reported Q4 results. Quarterly ...
Tags
GBT
Market News
Earnings
From
Benzinga
GBT Reports Recent Business Progress and Fourth Quarter and Full Year 2020 Financial Results
February 24, 2021
From
GlobeNewswire News Releases
The Daily Biotech Pulse: Bausch Calls Truce With Icahn, Pfizer's Brain Inflammation Vaccine Gets Priority Review, BriaCell IPO
February 24, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...
Tags
MMSI
News
IMRA
From
Benzinga
Is There Any Hope for bluebird bio Stock?
February 24, 2021
Investors are ditching this gene therapy stock en masse, for good reason.
Tags
GBT
BLUE
Market News
From
Motley Fool
Preview: Global Blood Therapeutics's Earnings
February 23, 2021
Global Blood Therapeutics (NASDAQ:GBT) announces its next round of earnings this Wednesday, February 24. Here is Benzinga's ...
Tags
Market News
GBT
BZI/EP
From
Benzinga
Analysts Forecast 11% Upside For IWF
February 23, 2021
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Tags
ETFs
From
ETF Channel
The Week Ahead In Biotech: J&J Vaccine Adcom Meeting, Sarepta FDA Decision And Plenty Of Earnings
February 20, 2021
Biotech stocks pulled back along with the broader market in the holiday-shortened week ended Feb 19. Earnings news flow was light before ...
Tags
ATRC
AXGN
OCDX
From
Benzinga
GBT Announces Participation in Upcoming Investor Conferences
February 19, 2021
From
GlobeNewswire News Releases
GBT to Announce Fourth Quarter and Full Year 2020 Financial Results on Wednesday, February 24, 2021
February 17, 2021
From
GlobeNewswire News Releases
GBT Announces New Employment Inducement Grants
February 05, 2021
From
GlobeNewswire News Releases
GBT Initiates Expanded Access Protocol for Oxbryta® (voxelotor) in Pediatric Patients with Sickle Cell Disease in the United States
February 04, 2021
From
GlobeNewswire News Releases
Notable Monday Option Activity: CLCT, GBT, TCS
February 01, 2021
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Collectors Universe Inc (CLCT), where a total volume of 2,001 contracts has been...
Tags
Stocks
From
Market News Video
European Medicines Agency Accepts GBT’s Marketing Authorization Application (MAA) for Oxbryta® (voxelotor) for the Treatment of Hemolytic Anemia in Sickle Cell Disease
January 27, 2021
From
GlobeNewswire News Releases
10 Biggest Price Target Changes For Wednesday
January 20, 2021
UBS boosted Netflix Inc (NASDAQ: NFLX) price target from $540 to $650. Netflix shares rose 13.6% to $570.03 in pre-market ...
Tags
BE
GBT
Price Target
From
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
January 11, 2021
Gainers Iridex (NASDAQ:IRIX) stock rose 29.02% to $3.69 during Monday's after-market session. This security traded at a volume of ...
Tags
After/Hours Center
Movers
Benzinga
From
Benzinga
GBT Announces New Employment Inducement Grants
January 07, 2021
From
GlobeNewswire News Releases
GBT Announces Participation at the 39th Annual J.P. Morgan Healthcare Conference
January 05, 2021
From
GlobeNewswire News Releases
10 Health Care Stocks With Unusual Options Alerts In Today's Session
December 21, 2020
This unusual options alert can help traders track potentially big trading opportunities. Traders often look for circumstances when the ...
Tags
Market News
BLUE
BZI/AUOA
From
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
27
28
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.